Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Performance of BRCA1/2 mutation prediction models in male breast cancer patients.

Autor: Moghadasi S; Department of Clinical Genetics, Leiden University Medical Centre, Leiden, the Netherlands., Grundeken V; Department of Clinical Genetics, Leiden University Medical Centre, Leiden, the Netherlands., Janssen LAM; Department of Clinical Genetics, Leiden University Medical Centre, Leiden, the Netherlands., Dijkstra NH; Dutch Breast Cancer Research Group, Amsterdam, the Netherlands., Rodríguez-Girondo M; Department of Medical Statistics and Bioinformatics, Leiden University Medical Centre, Leiden, the Netherlands., van Zelst-Stams WAG; Department of Human Genetics, Radboud University Medical Centre, Nijmegen, the Netherlands., Oosterwijk JC; Department of Genetics, University of Groningen, University Medical Centre Groningen, Groningen, the Netherlands., Ausems MGEM; Department of Genetics, University Medical Centre, Utrecht, the Netherlands., Oldenburg RA; Department of Clinical Genetics, Erasmus Medical Centre, Rotterdam, the Netherlands., Adank MA; Department of Clinical Genetics, VU University Medical Centre, Amsterdam, the Netherlands., Blom EW; Department Clinical Genetics, Maastricht University Medical Centre, Maastricht, the Netherlands., Ruijs MWG; Department of Clinical Genetics, the Netherlands Cancer Institute, Amsterdam, the Netherlands., van Os TAM; Department of Clinical Genetics, Academic Medical Centre, Amsterdam, the Netherlands., van Deurzen CHM; Department of Pathology, Erasmus Medical Centre, Rotterdam, the Netherlands., Martens JWM; Department of Medical Oncology, Erasmus Medical Centre, Rotterdam, the Netherlands., Schroder CP; Department of Medical Oncology, University of Groningen, University Medical Centre Groningen, Groningen, the Netherlands., Wijnen JT; Department of Clinical Genetics, Leiden University Medical Centre, Leiden, the Netherlands.; Department of Human Genetics, Leiden University Medical Centre, Leiden, the Netherlands., Vreeswijk MPG; Department of Human Genetics, Leiden University Medical Centre, Leiden, the Netherlands., van Asperen CJ; Department of Clinical Genetics, Leiden University Medical Centre, Leiden, the Netherlands.

Publikováno v: Clinical genetics [Clin Genet] 2018 Jan; Vol. 93 (1), pp. 52-59. Date of Electronic Publication: 2017 Sep 25.

Male breast cancer precursor lesions: analysis of the EORTC 10085/TBCRC/BIG/NABCG International Male Breast Cancer Program.

Autor: Doebar SC; Department of Pathology, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, The Netherlands., Slaets L; The European Organisation for Research and Treatment of Cancer Headquarters, Brussels, Belgium., Cardoso F; Breast Unit, Champalimaud Clinical Center/Champalimaud Foundation, Lisbon, Portugal., Giordano SH; Departments of Health Services Research and Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Bartlett JM; Transformative Pathology, Ontario Institute for Cancer Research, Toronto, Canada & University of Edinburgh, Scotland, UK., Tryfonidis K; The European Organisation for Research and Treatment of Cancer Headquarters, Brussels, Belgium., Dijkstra NH; BOOG Study Center/Dutch Breast Cancer Research Group, Amsterdam, The Netherlands., Schröder CP; Department of Medical Oncology, University Medical Center Groningen, Groningen, The Netherlands.; BOOG Study Center/Dutch Breast Cancer Research Group, Amsterdam, The Netherlands., van Asperen CJ; Department of Clinical Genetics, Leiden University Medical Center, Leiden, The Netherlands.; BOOG Study Center/Dutch Breast Cancer Research Group, Amsterdam, The Netherlands., Linderholm B; Department of Oncology, Swedish Association of Breast Oncologists (SABO), Sahlgrenska University Hospital, Gothenburg, Sweden., Benstead K; Department of Oncology, Cheltenham General Hospital, Gloucestershire, UK., Dinjens WN; Department of Pathology, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, The Netherlands., van Marion R; Department of Pathology, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, The Netherlands., van Diest PJ; Department of Pathology, University Medical Center Utrecht, Utrecht, The Netherlands., Martens JW; Department of Medical Oncology and Cancer Genomics Netherlands, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, The Netherlands.; BOOG Study Center/Dutch Breast Cancer Research Group, Amsterdam, The Netherlands., van Deurzen CH; Department of Pathology, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, The Netherlands.; BOOG Study Center/Dutch Breast Cancer Research Group, Amsterdam, The Netherlands.

Publikováno v: Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc [Mod Pathol] 2017 Apr; Vol. 30 (4), pp. 509-518. Date of Electronic Publication: 2017 Jan 13.